All News

This is the complete chapter on opioids in pregnancy and postpartum from Protocols for High-Risk Pregnancies, 7th Edition, edited by John T. Queenan, MD, Catherine Y. Spong, MD, and Charles J. Lockwood, MD, MHCM.

“Our ability to provide quality women’s health care to all women will depend on our willingness and commitment to change,” said editorial advisory board member Laura Riley, MD.

It was a very busy week for the Contemporary OB/GYN team.

A challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.

In this protocol, Terplan reviews screening for substance use and diagnosis and management of addiction during pregnancy, labor and delivery, and postpartum. The information is presented against the backdrop of the current opioid crisis. Tables on medication choice and protocols and on risk and protective factors for neonatal abstinence syndrome (NAS) are included.

The scoping review revealed target areas that require additional research, as well as a need for more variety in study designs, populations, and locations.

A major missed opportunity. Decades of effort including the development of guidance and implementation by individuals, groups, professional organizations, even the United States Congress, to address and facilitate inclusion of pregnant and lactating people in research and trials held no sway in the studies addressing the coronavirus disease 2019 (COVID-2019) pandemic.

A prospective study in the journal Ultrasound in Obstetrics & Gynecology has found that women treated with pelvic floor physiotherapy showed a significant improvement in pelvic floor relaxation, superficial dyspareunia and chronic pelvic pain, in comparison to women who did not receive treatment.

Obstetric providers can play a central role in identifying patients with opioid use disorder and linking them to life-saving treatment.

A study in the Journal of Obstetrics and Gynaecology found that dienogest was effective in decreasing the size of endometrioma and reducing endometriosis-associated pain, along with a favorable safety and tolerability profile.

This month’s issue brings with it hope for a spring season that will see an easing of COVID-19 cases and deaths, despite new virus mutations.

The first of Contemporary OB/GYN's Meet the Board series features Editor in Chief, Catherine Y. Spong, MD in this episode of Pap Talk by Contemporary OB/GYN®.

A small percentage of women whose noninvasive prenatal testing (NIPT) results were negative regretted taking the test and blamed themselves, according to a 1-year postpartum questionnaire survey.

A public health screening program for Down syndrome in Quebec, Canada, found that cell-free DNA noninvasive prenatal testing (NIPT) could be implemented at the same cost as the current screening program, according to computer simulations.

The Centers for Disease Control and Prevention (CDC) has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for coronavirus 2019 disease (COVID-19).

A better understanding of the pathophysiology of uterine fibroids (UFs) will enable healthcare providers to deliver high-quality informed care to their patients, according to Ayman Al-Hendy, MD, PhD, a professor of ob/gyn at Pritzker School of Medicine, University of Chicago.

Some women are unable to choose noninvasive prenatal testing (NIPT), due to lack of insurance coverage, according to a pilot study in the Journal of Community Genetics.

Here's what to look forward to this week on Contemporary OB/GYN.

It was a busy week for the Contemporary OBGYN team.

Mike Tankersley, MD, MBA, discusses workflow tips that can help practices in their use of telehealth visits.

The two most common symptomatic types of uterine fibroids (UFs) are intramural and subserosal, according to an unpublished study from Jordan.

The single-dose vaccine is the third granted emergency use authorization in an effort to end the COVID-19 coronavirus pandemic.

Office of the Inspector General recommends CMS conduct targeted hospital reviews for possible upcoding violations.

Barry S. Zuckerman, MD, founder of Reach Out and Read, hopes to personalize the patient-doctor relationship with a new app called Small Moments.

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.

The American Heart Association published a special issue to discuss current research in cardiovascular disease and outcomes in women.

Since 2012, when South Carolina's Medicaid program became the first state Medicaid program to separate payment for the immediate postpartum placement of long-acting reversible contraception (LARC) from global maternity payment, a significantly greater number of mothers are using LARC, especially among adolescents.

Diverse Voices: COVID-19 and the Health of Women, a virtual speaker series run by the NIH Office of Research on Women’s Health (ORWH), presented compiled research on sex and gender disparities during the COVID-19 pandemic. In addition to identifying issues of concern, the webinar offered actions to improve women’s health despite sex and gender disadvantages.

When it comes to willingness to switch contraception method, a team of researchers has looked into whether method type, satisfaction with use, and confidence in correct use were independently associated with switching intentions.

The mechanism of action (MOA) of emergency contraceptive pills (ECPs) is frequently mischaracterized among the general public, according to authors of a recent study published in the journal Contraception.